OTCPK:NNHH.F

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

NHS Industries Ltd. engages in the development and rental of real estate properties and facilities in Canada.


Snowflake Analysis

Worrying balance sheet with weak fundamentals.

Share Price & News

How has NHS Industries's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: NNHH.F's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

-28.8%

NNHH.F

14.7%

US Real Estate

3.8%

US Market


1 Year Return

35.0%

NNHH.F

-7.5%

US Real Estate

9.7%

US Market

Return vs Industry: NNHH.F exceeded the US Real Estate industry which returned -10.5% over the past year.

Return vs Market: NNHH.F exceeded the US Market which returned 8.9% over the past year.


Shareholder returns

NNHH.FIndustryMarket
7 Day-28.8%14.7%3.8%
30 Day4625.0%26.7%11.4%
90 Day357.3%-13.3%6.8%
1 Year35.0%35.0%-6.9%-7.5%12.1%9.7%
3 Yearn/a-6.5%-8.6%36.2%27.2%
5 Yearn/a-13.8%-16.5%63.7%45.4%

Price Volatility Vs. Market

How volatile is NHS Industries's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is NHS Industries undervalued compared to its fair value and its price relative to the market?

3.41x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate NNHH.F's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate NNHH.F's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: NNHH.F is unprofitable, so we can't compare its PE Ratio to the Real Estate industry average.

PE vs Market: NNHH.F is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate NNHH.F's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: NNHH.F is overvalued based on its PB Ratio (3.4x) compared to the US Real Estate industry average (1.1x).


Next Steps

Future Growth

How is NHS Industries forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

19.9%

Forecasted Real Estate industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as NHS Industries has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Take a look at our analysis of NNHH.F’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access NHS Industries's filings and announcements here.
  • Explore growth companies in the Real Estate industry.

Past Performance

How has NHS Industries performed over the past 5 years?

-39.5%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: NNHH.F is currently unprofitable.

Growing Profit Margin: NNHH.F is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: NNHH.F is unprofitable, and losses have increased over the past 5 years at a rate of -39.5% per year.

Accelerating Growth: Unable to compare NNHH.F's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: NNHH.F is unprofitable, making it difficult to compare its past year earnings growth to the Real Estate industry (-6.4%).


Return on Equity

High ROE: NNHH.F has a negative Return on Equity (-156.85%), as it is currently unprofitable.


Next Steps

Financial Health

How is NHS Industries's financial position?


Financial Position Analysis

Short Term Liabilities: NNHH.F's short term assets (CA$527.4K) exceed its short term liabilities (CA$506.1K).

Long Term Liabilities: NNHH.F's short term assets (CA$527.4K) do not cover its long term liabilities (CA$561.1K).


Debt to Equity History and Analysis

Debt Level: NNHH.F's debt to equity ratio (102.4%) is considered high.

Reducing Debt: Insufficient data to determine if NNHH.F's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: NNHH.F has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: NNHH.F has less than a year of cash runway if free cash flow continues to reduce at historical rates of 18.5% each year


Next Steps

Dividend

What is NHS Industries's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate NNHH.F's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate NNHH.F's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if NNHH.F's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if NNHH.F's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of NNHH.F's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.0yrs

Average management tenure


CEO

Robert Nygren

0.33

Tenure

Mr. Robert Nygren serves as Chief Executive Officer and Director at NHS Industries Ltd. since February 27, 2020 and served as its Independent Director since December 30, 2019 until February 27, 2020. Mr. N ...


Leadership Team

NamePositionTenureCompensationOwnership
Carman Parente
President & Director10.42yrsCA$103.24k45.55% CA$1.0m
Chiu Chan
CFO & Director3.58yrsCA$88.24k10.51% CA$235.7k
David Johnson
General Counselno dataCA$88.43kno data
Robert Nygren
CEO & Director0.33yrno datano data
Ming Chiang
Chief Strategy Officer & Directorno datano data7.53% CA$168.9k

2.0yrs

Average Tenure

54yo

Average Age

Experienced Management: NNHH.F's management team is not considered experienced ( 2 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Carman Parente
President & Director10.42yrsCA$103.24k45.55% CA$1.0m
Chiu Chan
CFO & Director3.58yrsCA$88.24k10.51% CA$235.7k
Robert Nygren
CEO & Director0.33yrno datano data
Ming Chiang
Chief Strategy Officer & Directorno datano data7.53% CA$168.9k
Catherine Pike
Independent Director3.58yrsCA$91.75k1.11% CA$24.8k

3.6yrs

Average Tenure

60yo

Average Age

Experienced Board: NNHH.F's board of directors are considered experienced (3.6 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 47.3%.


Top Shareholders

Company Information

NHS Industries Ltd.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: NHS Industries Ltd.
  • Ticker: NNHH.F
  • Exchange: OTCPK
  • Founded: 2001
  • Industry: Real Estate Operating Companies
  • Sector: Real Estate
  • Market Cap: CA$3.032m
  • Listing Market Cap: CA$2.243m
  • Shares outstanding: 50.54m
  • Website: https://nhsindustries.ca

Location

  • NHS Industries Ltd.
  • 1641 Lonsdale Avenue
  • Suite 106
  • North Vancouver
  • British Columbia
  • V7M 2J5
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
NHSCNSX (Canadian National Stock Exchange)YesCommon SharesCACADApr 2018
NNHH.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDApr 2018

Biography

NHS Industries Ltd. engages in the development and rental of real estate properties and facilities in Canada. The company operates Langley Site is a five and a half acre agricultural property with a 48,000 square foot greenhouse facility on site; and a residential property. NHS Industries Ltd. was incorporated in 2001 and is headquartered in North Vancouver, Canada. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/06/05 05:59
End of Day Share Price2020/06/03 00:00
Earnings2019/09/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.